(Q67377639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

title

Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

0 references

1 reference

G. Rivera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1220978

2 September 2022

T. Avery

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1220978

2 September 2022

D. W. Roberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1220978

2 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1220978

2 September 2022

publication date

1 September 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

12 September 2019

https://api.elsevier.com/content/article/PII:0014296475900997?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

https://api.elsevier.com/content/article/PII:0014296475900997?httpAccept=text/plain

1 November 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

European Journal of Cancer

1 November 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

page(s)

639-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action

12 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

1 November 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

4′-Demethyl-epipodophyllotoxin-β-d-thenylidene glucoside (VM-26)—A brief review

1 November 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis

1 November 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

The chemotherapy of human and animal acute leukemia

1 November 2023

18

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

Decrease in oncogenic potential of L1210 leukemia by triazenes

1 November 2023

27

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

Modification of tumor regression by immunologic means

1 November 2023

28

1 reference

https://api.crossref.org/works/10.1016/0014-2964(75)90099-7

1 November 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1220978%20AND%20SRC:MED&resulttype=core&format=json

12 September 2019

1 reference